125 related articles for article (PubMed ID: 30884066)
1. Myocardial metaiodobenzylguanidine tomoscintigraphy for the diagnosis of Lewy body disease in patients with high clinical suspicion and non-diagnostic ioflupane single-photon emission computed tomography.
Le Moine M; Cytryn E; Hambye AS; Bizimungu A; Colson C; Surquin M; Segers K
Psychogeriatrics; 2019 Nov; 19(6):624-625. PubMed ID: 30884066
[No Abstract] [Full Text] [Related]
2. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
[TBL] [Abstract][Full Text] [Related]
3. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
[TBL] [Abstract][Full Text] [Related]
4. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic.
Tateno F; Sakakibara R; Kishi M; Ogawa E; Terada H; Ogata T; Haruta H
Parkinsonism Relat Disord; 2011 Jun; 17(5):395-7. PubMed ID: 21342781
[No Abstract] [Full Text] [Related]
6. Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases.
Lebasnier A; Lamotte G; Manrique A; Peyronnet D; Bouvard G; Defer G; Agostini D
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1043-51. PubMed ID: 25626701
[TBL] [Abstract][Full Text] [Related]
7. Current role and future perspectives of radioiodinated MIBG in the evaluation of dementia with Lewy bodies.
Treglia G; Ceriani L; Giovanella L
Curr Radiopharm; 2014; 7(1):75-8. PubMed ID: 24635146
[TBL] [Abstract][Full Text] [Related]
8. Clinical validity of presynaptic dopaminergic imaging with
Sonni I; Ratib O; Boccardi M; Picco A; Herholz K; Nobili F; Varrone A;
Neurobiol Aging; 2017 Apr; 52():228-242. PubMed ID: 28317651
[TBL] [Abstract][Full Text] [Related]
9. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [
Fujishiro H; Okuda M; Iwamoto K; Miyata S; Torii Y; Iritani S; Ozaki N
Psychiatry Clin Neurosci; 2018 Jun; 72(6):423-434. PubMed ID: 29536584
[TBL] [Abstract][Full Text] [Related]
10. Improving diagnosis of possible DLB: is there a role for MIBG myocardial scintigraphy?
Ballard C; Grimmer T
Neurology; 2013 Nov; 81(20):1730-1. PubMed ID: 24122184
[No Abstract] [Full Text] [Related]
11. Meta-analysis of 123I-MIBG cardiac scintigraphy for the diagnosis of Lewy body-related disorders.
King AE; Mintz J; Royall DR
Mov Disord; 2011 Jun; 26(7):1218-24. PubMed ID: 21480373
[TBL] [Abstract][Full Text] [Related]
12. Complementary role of 18F-FDG PET and 123I-ioflupane SPECT in the diagnosis of Lewy body disease.
Jolepalem P; Balon HR; Wong CY; Wu D
J Nucl Med Technol; 2014 Sep; 42(3):233-4. PubMed ID: 25033885
[TBL] [Abstract][Full Text] [Related]
13. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
Hanyu H; Shimizu S; Hirao K; Kanetaka H; Iwamoto T; Chikamori T; Usui Y; Yamashina A; Koizumi K; Abe K
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506
[TBL] [Abstract][Full Text] [Related]
14. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
[TBL] [Abstract][Full Text] [Related]
15. Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses.
Lamotte G; Morello R; Lebasnier A; Agostini D; Defer GL
BMC Neurol; 2015 May; 15():83. PubMed ID: 25971430
[TBL] [Abstract][Full Text] [Related]
16. From the heart to the brain via cardiac MIBG imaging.
Estorch M
Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):246-7. PubMed ID: 16328504
[No Abstract] [Full Text] [Related]
17. [Improved diagnosis of dementia with Lewy bodies by the combination of 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy and 99mTc-ethylcysteinate dimmer (ECD) brain perfusion SPECT].
Kobayashi S; Tateno M; Furukawa Y; Shirasaka T; Utumi K
Seishin Shinkeigaku Zasshi; 2008; 110(4):285-91. PubMed ID: 18593002
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of dementia with Lewy bodies: can
Sakamoto F; Shiraishi S; Tsuda N; Hashimoto M; Tomiguchi S; Ikeda M; Yamashita Y
Br J Radiol; 2017 Feb; 90(1070):20160156. PubMed ID: 27897064
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
Tateno M; Kobayashi S; Shirasaka T; Furukawa Y; Fujii K; Morii H; Yasumura S; Utsumi K; Saito T
Dement Geriatr Cogn Disord; 2008; 26(5):453-7. PubMed ID: 18974648
[TBL] [Abstract][Full Text] [Related]
20.
Nuvoli S; Palumbo B; Malaspina S; Madeddu G; Spanu A
Hell J Nucl Med; 2018; 21(1):60-68. PubMed ID: 29550847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]